Skip to content

A Clinical study to evaluate effect of single ayurvedic drug therapy in Pandu (Iron deficiency Anaemia)

Randomised Controlled Clinical Trial Study To Compare The Efficiency Of Yashtimadhu Kwath With Vasadi Kwath In Management Of Pandu (Iron Deficiency Anaemia) - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062297
Enrollment
80
Registered
2024-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D759- Disease of blood and blood-formingorgans, unspecified Health Condition 2: D759- Disease of blood and blood-formingorgans, unspecified

Interventions

None listed

Sponsors

Tilak Ayurved Mahavidyalaya,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women of reproductive age group of 15 to 49 years patients diagnosed with iron deficiency anaemia patients having symptoms of panduta, dourbalya, shwas,hritspandan, akshi koot shoth patients having haemoglobin less than 12

Exclusion criteria

Exclusion criteria: patients having haemoglobin less than 7 patient suffering from haematological disorder,gynacological diseases and systemic disorders pregnant females and lactating mothers

Design outcomes

Primary

MeasureTime frame
Minimum 50% increase in Hb should be observed after the completion of the trial in 60 daysTimepoint: Baseline, 15th day, 30th day, 45th day, 60th day

Secondary

MeasureTime frame
recurrence of pallor,generalized weakness, dyspnoea,giddinesTimepoint: 60 days

Countries

India

Contacts

Public ContactDr Sadanand V Deshpande

Tilak Ayurved Mahavidyalaya, Pune

drsvdeshpande61@gmail.com9960071113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026